Skip to main content
Ultrasound in PsA
RheumNow’s expanded coverage of the #ACR22 Annual meeting is sponsored in part by Novartis. All content chosen by Rheu

Dr. John Cush RheumNow

3 years 11 months ago
RheumNow’s expanded coverage of the #ACR22 Annual meeting is sponsored in part by Novartis. All content chosen by RheumNow & its Faculty.
RT @RichardPAConway: Curtis et al. Primary non-adherence to csDMARDs and b/tsDMARDs in RA/PsA/SpA. Medicare and commeric

Richard Conway RichardPAConway

3 years 11 months ago
Curtis et al. Primary non-adherence to csDMARDs and b/tsDMARDs in RA/PsA/SpA. Medicare and commerically-insured patients. 20-44%! of new prescriptions not filled by 6 months. Higher for csDMARDs than b/tsDMARDs @RheumNow #ACR22 Abstr#2199 https://t.co/Pwg6GKu7Gg https://t.co/wPF0pu1UDa
RT @AkhilSoodMD: Abstr #2192 risk of serious infxn in newborns of mothers on TNFi by placental transfer
- % serious infe

Akhil Sood MD AkhilSoodMD

3 years 11 months ago
Abstr #2192 risk of serious infxn in newborns of mothers on TNFi by placental transfer - % serious infection in TNFi in high vs low placental transfer (2.1% vs 1.6%) - HR (high vs low) 0.98 (95% CI 0.36-2.61) - No significant difference in risk of serious infxn @RheumNow #ACR22 https://t.co/7Lfpf7PERu
RT @DrCassySims: Which patients with IIM are high risk for #cancer?

Abstract #0002 #ACR22 @RheumNow #ACRBest

📍Der

Catherine Sims, MD DrCassySims

3 years 11 months ago
Which patients with IIM are high risk for #cancer? Abstract #0002 #ACR22 @RheumNow #ACRBest 📍Dermatomyositis 📍Anti-TIF-gamma, anti-NXP2 📍Age > 40y at dz onset 📍Dysphagia 📍Cutaneous necrosis 📍Persistent high dz despite immunosuppressive tx
RT @drdavidliew: Which is better for CV risk in RA:
triple therapy DMARDs or TNFi?

TARGET study
n=159 using PET/CT sur

David Liew drdavidliew

3 years 11 months ago
Which is better for CV risk in RA: triple therapy DMARDs or TNFi? TARGET study n=159 using PET/CT surrogate (endpoint responsiveness👀) - either led to benefit - both equally good - benefit *not* linked to change in DAS28 A direct CV effect of RA Rx? ABST2215 #ACR22 @RheumNow https://t.co/4FPvSbfGsD
RT @synovialjoints: Vaccination +/- prior Covid-19, and with either mRNA or vectored DNA vaccines were not associated wi

Dr. Antoni Chan synovialjoints

3 years 11 months ago
Vaccination +/- prior Covid-19, and with either mRNA or vectored DNA vaccines were not associated with AIRD flares. Negative association 21-days after 1st Covid-19 vaccination and no association after 2nd or 3rd doses. Nakafero G Abs#2194 https://t.co/vA8cMNQGkr #ACR22 @RheumNow https://t.co/SZnXejnmYt
RT @RichardPAConway: Singh @NamrataRheum et al. Frailty in patients treated bDMARD/tsDMARD assoc serious infections aHR

Richard Conway RichardPAConway

3 years 11 months ago
Singh @NamrataRheum et al. Frailty in patients treated bDMARD/tsDMARD assoc serious infections aHR 1.34, any infection aHR 1.18, hospitalisation aHR 1.34 (all relative non-frail). @RheumNow #ACR22 Abstr#2218 https://t.co/ONsTBq8ehB https://t.co/iTVANh5flk
RT @ericdeinmd: Thieves Market #ACR22
Ulcerative palatal lesions, non-spec bx
+ANA 1:320 w other neg Abs
Empiric steroid

Eric Dein ericdeinmd

3 years 11 months ago
Thieves Market #ACR22 Ulcerative palatal lesions, non-spec bx +ANA 1:320 w other neg Abs Empiric steroids for presumed vasculitis New cavitary lung lesion. Pathology showed vasculitis Dacrocystitis w lobulated paranasal mass Dx: Extra nodal NK/T-cell lymphoma Fatal case @RheumNow https://t.co/TlDy9GfW7N
RT @RichardPAConway: Flatman et al. Risk of infections in children with third trimester TNFi use, high vs low (CTZ, ETN)

Richard Conway RichardPAConway

3 years 11 months ago
Flatman et al. Risk of infections in children with third trimester TNFi use, high vs low (CTZ, ETN) placental transfer. No difference but wide CIs, aHR 0.98 (0.36, 2.61) @RheumNow #ACR22 Abstr#2192 https://t.co/350UxX9bkL https://t.co/29uOtek8w7
RT @AurelieRheumo: 💤cognitive behavioural therapy 2 hours/wk for 6 wks for insomnia improves RA PROs at 26 wks

Insom

Aurelie Najm AurelieRheumo

3 years 11 months ago
💤cognitive behavioural therapy 2 hours/wk for 6 wks for insomnia improves RA PROs at 26 wks Insomnia Severity Index -9.8 RAID -1.4 PGA -13 Small sample size wk6 trend improvement sleep efficiency 89% vs84% p=0.07 but not wk26 https://t.co/rpKdtbREYs Abs#2188 #ACR22 @RheumNow https://t.co/kEBcPAdIKW
RT @uptoTate: Interesting Abs 1997 finds butyrate supplementation in RA assoc'd w/changes in human gut microbiota compos

Dr. Rachel Tate uptoTate

3 years 11 months ago
Interesting Abs 1997 finds butyrate supplementation in RA assoc'd w/changes in human gut microbiota composition and in peripheral Treg abundance and markers of Treg activation. More data needed to determine clinical/dz activity relevence. #ACR22 @RheumNow https://t.co/tQocYUU0Er
RT @bella_mehta: #PregnantWoman with #sle - n = 873
Highest overall adverse events in Preexisting HTN
complicated by ra

Bella Mehta bella_mehta

3 years 11 months ago
#PregnantWoman with #sle - n = 873 Highest overall adverse events in Preexisting HTN complicated by race We have a Modifiable risk factor - HTN to work closely abst#2107 @rheumnow #ACR22 #ACRBest https://t.co/EC8c7Dzrvs https://t.co/Jydz0uo1bv
RT @AurelieRheumo: Interosseous tendon inflammation (ITI) the new predictor of clinical RA in pts w/ clinically suspect

Aurelie Najm AurelieRheumo

3 years 11 months ago
Interosseous tendon inflammation (ITI) the new predictor of clinical RA in pts w/ clinically suspect arthralgia. 600+ pts Hands MRI Present 10% pts w/ CSA, 1% symptom free 27% ACPA+ 7% ACPA- HR 4.5 dvlpmt of clinical RA https://t.co/BmRF1tLFx9 Abs#2204 #ACR22 @RheumNow https://t.co/F8DUxiI2dh
×